Mechanisms of normal and abnormal endometrial bleeding
1Department of Obstetrics, Gynecology and Reproductive Sciences, Yale University School of Medicine, 333 Cedar Street, Room 314 FMB, PO Box 208063, New Haven, CT 06520-8063, USA. Charles.Lockwood@yale.edu
Progesterone stabilizes the endometrium by promoting hemostasis and inhibiting matrix breakdown, preventing hemorrhage. Progestin-only contraceptives disrupt this by promoting abnormal angiogenesis, leading to fragile endometrial vessels and bleeding.
Area of Science:
- Reproductive Biology
- Endocrinology
- Gynecologic Pathology
Background:
- The endometrium undergoes dynamic biochemical changes regulated by progesterone during the luteal phase to ensure successful implantation and gestation.
- Key hemostatic factors like tissue factor (TF) and plasminogen activator inhibitor-1 (PAI-1) are upregulated by progesterone, while matrix metalloproteinases (MMPs) are downregulated to maintain endometrial stability.
- Dysregulation of these processes contributes to abnormal uterine bleeding.
Purpose of the Study:
- To elucidate the molecular mechanisms by which progesterone regulates endometrial hemostasis and vascular integrity.
- To understand the pathophysiology of abnormal uterine bleeding in conditions such as anovulation and with progestin-only contraceptive use.
- To investigate the role of angiogenesis in abnormal endometrial bleeding.
Main Methods:
- Analysis of human endometrial stromal cells (HESC) expression of TF, PAI-1, and MMPs under varying hormonal conditions.
- Investigation of the effects of progesterone withdrawal on endometrial hemostatic and proteolytic factors.
- Assessment of angiogenic and angiostatic factor expression in response to progestin-induced endometrial hypoxia.
Main Results:
- Progesterone enhances TF and PAI-1 expression and inhibits MMPs in decidualized HESCs, promoting a hemostatic and stable endometrium.
- Progesterone withdrawal leads to decreased TF/PAI-1 and increased MMPs, facilitating menstruation.
- Progestin-only contraceptives induce abnormal angiogenesis via VEGF and Ang-2 upregulation and Ang-1 downregulation, leading to fragile endometrial vessels and bleeding.
Conclusions:
- Progesterone plays a critical role in maintaining endometrial hemostasis and vascular stability through coordinated regulation of TF, PAI-1, and MMPs.
- Abnormal uterine bleeding can result from either impaired hemostasis or dysregulated angiogenesis.
- Understanding these mechanisms is crucial for diagnosing and managing various gynecologic bleeding disorders.
More Related Videos
09:15Two Methods for Establishing Primary Human Endometrial Stromal Cells from Hysterectomy Specimens
Published on: May 23, 2014
06:22Ex Vivo Method for Assessing the Mouse Reproductive Tract Spontaneous Motility and a MATLAB-based Uterus Motion Tracking Algorithm for Data Analysis
Published on: September 1, 2019
Related Concept Videos
Disorders of Hemostasis
Thromboembolic Disorders
Two factors primarily cause thromboembolic conditions.
The Menstrual Cycle
The menstrual phase occurs from days 1 to 5 and involves the shedding of the stratum functionalis, as a uterine...
Menses Phase
When fertilization does not occur, the corpus luteum deteriorates, causing a significant drop in the levels of estrogen and progesterone in the body. This hormonal decrease triggers the release of prostaglandins, which cause the uterine...
Hormonal Regulation of the Menstrual Cycle
At puberty, GnRH begins a pulsatile release pattern, which triggers the anterior pituitary gland to secrete follicle-stimulating hormone (FSH) and luteinizing hormone (LH). The frequency and amplitude of GnRH pulses vary across the menstrual cycle, with faster pulses favoring LH release and slower pulses favoring FSH release.
Disorders of the Female Reproductive System
Histology of the Uterus
The endometrium is the...
